drugset / Trial / NCT05702489

A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

NCT05702489

Phase 2/3 Completed 900 enrolled Nanjing Zenshine Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to compare ZX-7101A in Chinese Adults patients with uncomplicated influenza. The main questions it aims to answer are: * The efficacy of ZX-7101A in Chinese Adults patients with uncomplicated influenza. * The safety of ZX-7101A in Chinese Adults patients with uncomplicated influenza.

Timeline

Start
2022-07-17
Primary completion
2023-05-26
Completion
2023-10-13

Drugs

EvaluationDrugModalityDoseRoute
Subject ZX-7101A Unknown 40 mg Oral
Subject ZX-7101A Unknown 80 mg Oral

Indications